<DOC>
	<DOCNO>NCT01828697</DOCNO>
	<brief_summary>This randomized-controlled open-label trial compare two different dos low-molecular-weight heparin ( LMWH ) pregnant patient history previous venous thromboembolism ( VTE ) . Both dos recommend dos 2012 guideline American College Chest Physicians ( ACCP ) , know dose efficacious prevent recurrent venous thromboembolism pregnancy . Patients enter study randomize soon home test confirm pregnancy . LMWH administer 6 week postpartum . Follow-up continue 3 month postpartum . Patients recruit treat physician , either obstetrician internist .</brief_summary>
	<brief_title>Comparison Low Intermediate Dose Low-molecular-weight Heparin Prevent Recurrent Venous Thromboembolism Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Tinzaparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<criteria>Age : 18 year old , ; Pregnancy confirm urinary pregnancy test , ; Gestational age &lt; 14 week , ; Previous objectively confirm VTE , either unprovoked , presence use oral contraceptive estrogen/progestagen use , related pregnancy postpartum period , minor risk factor ( e.g . long distance travel , minor trauma ) . Previous VTE relate major provoking risk factor ( e.g . surgery , major trauma plaster cast immobilisation 3 month prior VTE ) sole risk factor , ; Indication treatment therapeutic dose anticoagulant therapy ( e.g . treatment acute VTE ; permanent use therapeutic anticoagulant outside pregnancy ) , ; Inability provide inform consent , ; Any contraindication list local labelling LMWH .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Low-molecular-weight heparin</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Venous thrombosis</keyword>
</DOC>